1. Drugging the undruggable- targeting wild type EGFR with exosomal therapeutics National Medical Research Council Clinical Scientist Individual Research Grant (CIRG21jun-0035) for $1,494,200; Feb 2022 to 31 Jan 2025) – currently ongoing
2. Precision oncology approach to identification and expansion of tumour-targeting cytotoxic T-lymphocytes in head and neck squamous cell cancer. National Medical Research Council Clinician Scientist Award – Senior Investigator Grant (MOH-000325) for $1,748,900; Jan 2020 to Dec 2024) – currently ongoing
3. Precision immunotherapy for gastric, and head and neck cancer targeting the MARK3 splice variant antigen. National Health Innovation Centre Singapore I2D grant (NHIC-I2D-1912237) for $250,000; Aug 2020- Jul 2021) as CO-I
4. Next-generation lung cancer clinical trials. National Medical Research Council Large Collaborative grant for $1,130,000; May 2018 – Apr 2023 as theme PI
5. The Role of Tumor Heterogeneity in Lymph Node Metastasis in Oral Squamous Cell Carcinoma (OSCC): A Precision Medicine Approach (NMRC/CSA-INV/0011/2016 for $1,200,000; Nov 2016 - Oct 2019)